Popular Articles

QIAGEN Launches Novel Product Enabling Non-Invasive Prenatal Diagnostics And Cancer Detection
QIAGEN announced the launch of a novel product for extraction of free circulating fragments of tumor- and fetal-derived nucleic acids as well as viral nucleic acids in human blood. Scientists consider these DNA and RNA fragments to have great potential for the highly sensitive and non-invasive diagnosis of a wide range of diseases, including congenital disorders, malignancies such as colon and lung cancer, and infections. The new QIAamp Circulating Nucleic Acid Kit is expected to significantly facilitate the corresponding biomarker research and the introduction of novel molecular tests in prenatal diagnostics which can replace risky, invasive procedures such as amniocentesis.
generic viagra online
Response To Compression Stocking Study In The Lancet
Dr Peter Coleman, Deputy Director of Research at The Stroke Association said:
News of the day
Pfizer To Give Away 70 Of Its Most Widely Prescribed Drugs To Those Who Lost Jobs
Pfizer on Thursday announced a new program that would provide some of its existing customers access to more than 70 types of medications at no cost if they have recently been laid off or lost their prescription drug coverage, USA Today reports. The program -- called MAINTAIN, or Medicines Assistance for Those who Are in Need -- will begin July 1. To receive the drugs, individuals must show that they have been unemployed since Jan. 1 and that they no longer have prescription drug insurance. They also must prove that they cannot pay for their medications and that they were taking a medication listed under the program for at least three months prior to losing their jobs. Those who meet the eligibility requirements would receive their medications at no cost for up to one year, or until they have insurance coverage. Pfizer will accept applications through Dec. 31 (Petrecca, USA Today, 5/15).According to the AP/Detroit News, medications listed for the new patient drug-assistance program include some of Pfizer"s "top money makers," such as the anti-cholesterol drug Lipitor, the painkiller Celebrex, the fibromyalgia treatment Lyrica and the impotency treatment Viagra (Johnson, AP/Detroit News, 5/14).Ray Kerins, a spokesperson for Pfizer, declined to reveal how much the program would cost the pharmaceutical company or how many potential customers might benefit from it (Bloomberg/Miami Herald, 5/15).According to the AP/News, the program "could earn Pfizer some goodwill" after "long being a target of critics of drug industry prices and sales practices" (AP/Detroit News, 5/14). Scott Morgan, president of ad agency Brunner, said, "It goes beyond goodwill. There"s definitely a marketing strategy behind this about defending against generics and maintaining your consumer base. ... It"s a pretty savvy move" (USA Today, 5/15).
Nutrition

Delaware State Senate Passes Bill Aimed At Reducing Mother-To-Child HIV Transmission

The Delaware State Senate recently passed a bill (SB 86) that would add HIV testing to the standard battery of tests given to all pregnant women, WMTD.com reports. Lawmakers hope that the bill will help reduce the rate of mother-to-child HIV transmission. Women would be able to choose to "opt out" of taking the test, according to WMTD.com (Saki, WMTD.com, 6/14). This information was reprinted from dailyreports.kff.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily U.S. HIV/AIDS Report, search the archives and sign up for email delivery at dailyreports.kff.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):